Effect of statins on toll-like receptors: a new insight to pleiotropic effects

被引:149
作者
Bahrami, Afsane [1 ]
Parsamanesh, Negin [2 ]
Atkin, Stephen L. [3 ]
Banach, Maciej [4 ,5 ]
Sahebkar, Amirhossein [6 ,7 ,8 ]
机构
[1] Birjand Univ Med Sci, Cellular & Mol Res Ctr, Birjand, Iran
[2] Birjand Univ Med Sci, Student Res Comm, Birjand, Iran
[3] Weill Cornell Med Qatar, Doha, Qatar
[4] Med Univ Lodz, WAM Univ Hosp Lodz, Dept Hypertens, Zeromskiego 113, Lodz, Poland
[5] PMMHRI, Lodz, Poland
[6] Mashhad Univ Med Sci, Neurogen Inflammat Res Ctr, Mashhad, Iran
[7] Mashhad Univ Med Sci, Pharmaceut Technol Inst, Biotechnol Res Ctr, Mashhad, Iran
[8] Mashhad Univ Med Sci, Sch Pharm, Mashhad, Iran
关键词
HMG-CoA reductase; TLR; Inflammation; Atherosclerosis; Statins; KAPPA-B ACTIVATION; VASCULAR SMOOTH-MUSCLE; CORONARY-HEART-DISEASE; RHEUMATOID-ARTHRITIS; TOLL-LIKE-RECEPTOR-4; EXPRESSION; SIGNALING PATHWAY; ATHEROSCLEROTIC PLAQUES; INFLAMMATORY MEDIATORS; CYTOKINE PRODUCTION; ENDOGENOUS LIGANDS;
D O I
10.1016/j.phrs.2018.08.014
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The toll-like receptors (TLRs) are a class of transmembrane-spanning receptors that are sentinels of both innate and adaptive immunity. Statins (3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors) are the most commonly prescribed therapeutic agents for treating hypercholesterolemia globally. However, statin therapy appears to have pleiotropic effects including attenuation of chronic low-grade inflammation and modulation of TLR activity. Statins through abolition of TLR4 expression and regulation of the TLR4/Myd88/NF-kappa B signaling pathway may slow the progression of atherosclerosis and other inflammatory diseases. In this review, we have focused on the impact and mechanism of action of statins on cardiovascular and non-cardiovascular diseases.
引用
收藏
页码:230 / 238
页数:9
相关论文
共 136 条
[21]   PROTEIN LIPIDATION IN CELL SIGNALING [J].
CASEY, PJ .
SCIENCE, 1995, 268 (5208) :221-225
[22]   Atorvastatin affects TLR4 clustering via lipid raft modulation [J].
Chansrichavala, Praveen ;
Chantharaksri, Udom ;
Sritara, Piyamitr ;
Ngaosuwankul, Nathamon ;
Chaiyaroj, Sansanee C. .
INTERNATIONAL IMMUNOPHARMACOLOGY, 2010, 10 (08) :892-899
[23]  
Chansrichavala P, 2009, ASIAN PAC J ALLERGY, V27, P49
[24]   Innate Immune System Cells in Atherosclerosis [J].
Chavez-Sanchez, Luis ;
Espinosa-Luna, Jose E. ;
Chavez-Rueda, Karina ;
Legorreta-Haquet, Maria V. ;
Montoya-Diaz, Eduardo ;
Blanco-Favela, Francisco .
ARCHIVES OF MEDICAL RESEARCH, 2014, 45 (01) :1-14
[25]   Simvastatin reduces secondary brain injury caused by cortical contusion in rats: Possible involvement of TLR4/NF-κB pathway [J].
Chen, Gang ;
Zhang, Shiming ;
Shi, Jixin ;
Ai, Jinglu ;
Qi, Meng ;
Hang, Chunhua .
EXPERIMENTAL NEUROLOGY, 2009, 216 (02) :398-406
[26]   A cellular Micro-RNA, let-7i, regulates toll-like receptor 4 expression and contributes to cholangiocyte immune responses against Cryptosporidium parvum infection [J].
Chen, Xian-Ming ;
Splinter, Patrick L. ;
O'Hara, Steven P. ;
LaRusso, Nicholas F. .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2007, 282 (39) :28929-28938
[27]   Immunomodulation by statins: mechanisms and potential impact on autoimmune diseases [J].
Chow, Sek C. .
ARCHIVUM IMMUNOLOGIAE ET THERAPIAE EXPERIMENTALIS, 2009, 57 (04) :243-251
[28]   Impact of statin therapy on plasma adiponectin concentrations: A systematic review and meta-analysis of 43 randomized controlled trial arms [J].
Chrusciel, Piotr ;
Sahebkar, Amirhossein ;
Rembek-Wieliczko, Magdalena ;
Serban, Maria-Corina ;
Ursoniu, Sorin ;
Mikhailidis, Dimitri P. ;
Jones, Steven R. ;
Mosteoru, Svetlana ;
Blaha, Michael J. ;
Martin, Seth S. ;
Rysz, Jacek ;
Toth, Peter P. ;
Lip, Gregory Y. H. ;
Pencina, Michael J. ;
Ray, Kausik K. ;
Banach, Maciej .
ATHEROSCLEROSIS, 2016, 253 :194-208
[29]  
Cicero AFG, 2017, NUTR REV, V75, P731, DOI [10.1093/nutrit/nux047, 10.5114/aoms.2017.69326]
[30]  
Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3